News
Statistical evidence from meta-analysis of VIVIAD and VIVA-MIND enables efficient design of Phase 2b study in diabetic kidney disease (DKD), ideally suited to evaluate varoglutamstat in the intended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback